Pregabalin Premedication for Knee Arthroscopy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03926000|
Recruitment Status : Not yet recruiting
First Posted : April 24, 2019
Last Update Posted : April 24, 2019
Information provided by (Responsible Party):
Dr Ezzeldin Ibrahim, Menoufia University
Outpatient arthroscopic knee surgery can be performed with general or regional anesthesia. Recent data suggest that spinal and epidural anesthesia require longer discharge times than the newer shorter-acting general anesthetic drugs. Ideal premedication drug should relieve anxiety, produce amnesia and sedation, decrease secretions, prevent nausea and vomiting, have dose sparing effect on the anaesthetic drugs, and suppress pressor response to laryngoscopy and intubation. Recently, gabapentin and pregabalin were suggested as pre-operative drugs to decrease anxiety, stress response to laryngoscopy and post operative pain.
|Condition or disease||Intervention/treatment||Phase|
|Knee Arthroscopy||Drug: Pregabalin (PG) Drug: Control placebo (C)||Not Applicable|
112 patients undergoing elective knee arthroscopy will randomly divided into two equal groups, 56 patients each. All patients will receive premedication one hour before the procedure. PG group will receive 150 mg pregabalin and C group will receive placebo. All patients will receive total intravenous anesthesia to achieve optimum working conditions. Intra-operative total amount of anesthetics will be compared in both groups.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||112 participants|
|Intervention Model:||Crossover Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||The Effect of Pregabalin Premedication on Anaesthetic Requirements and Recovery Time After Knee Arthroscopy|
|Estimated Study Start Date :||June 2019|
|Estimated Primary Completion Date :||November 2019|
|Estimated Study Completion Date :||December 2019|
Active Comparator: Pregabalin (PG)
Patients will receive 150 mg pregabalin one hour before the procedure.
Drug: Pregabalin (PG)
Pregabalin 150 mg one hour before the procedure as premedication.
Other Name: Pregabalin for premedication
Placebo Comparator: Control placebo (C)
Patients will receive placebo tablet one hour before surgery.
Drug: Control placebo (C)
Placebo tablets one hour before the procedure as premedication.
Other Name: Placebo for premeditation.
Primary Outcome Measures :
- Total amount of anesthetics [ Time Frame: 45 minutes during the procedure ]Total amount of anesthetics used during the procedure.
Secondary Outcome Measures :
- Patients' satisfaction: satisfaction score [ Time Frame: 30 minutes after the end of the procedure ]Patient's satisfaction score will be recorded using a score ranging from 0 not satisfied and 5 totally satisfied. The score will be done using a questioner designed by the researchers.
No Contacts or Locations Provided